España
India
Italia
대한민êµ
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Revive Therapeutics
RVVTF
OTCQB
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.007300
-0.0004
-5.19%
At close: -
Get Report
Comment
Revive Therapeutics (RVVTF) Forecast
News
Earnings
Revive Therapeutics (RVVTF) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Revive Therapeutics (OTC:RVVTF) Stock
Revive Therapeutics Stock (OTC: RVVTF)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, July 31, 2024
EXCLUSIVE: Legal Magic Mushroom Products Will Be Sold In Jamaica As Psilocybin Products Hit Pharmacy Shelves
Javier Hasse
Wednesday, April 05, 2023
Psyched: Canada's Case For Psilocybin Access And Microdose Trial, US Reform Update, Battle With DEA & More
Lara Goldstein
Monday, April 03, 2023
MDMA Transdermal Patch Moves Toward First-In-Human Trials: Latest Development Update
Lara Goldstein
Tuesday, March 28, 2023
Meth Use Disorder Tackled With Psilocybin: Clinical Trial Begins Patient Enrollment
Lara Goldstein
Monday, February 13, 2023
Psyched: 12 States Discuss Legalization Bills, Ceremonies For Veterans With TBI, Ketamine And MDMA Fast-Tracks & More
Lara Goldstein
Monday, February 06, 2023
MDMA News: Optimi's New Drug Now Available, Revive Advances Transdermal Patch Evaluations
Lara Goldstein
Friday, February 03, 2023
PharmaTher Holdings Nabs New Orphan Drug Status, Discusses Further Fast-Track, Partners For MDMA Patch
Lara Goldstein
Tuesday, January 17, 2023
Psyched: Psychedelics In Davos, Prince Harry In The 90s, Cathie Wood's Latest Moves And More
Lara Goldstein
Thursday, January 12, 2023
Psychedelics Company Revive Raises $3.2M To Target Infectious Diseases, Disorders
Lara Goldstein
Tuesday, December 20, 2022
Psyched: First Ayahuasca Pill Created, Psychedelics Legalization Predicted, UK's Research Support And More
Lara Goldstein
Friday, December 16, 2022
Psyence, Revive Therapeutics Ink Private Placements: Capital To Support Drug Trials
Lara Goldstein
Thursday, December 01, 2022
Revive Therapeutics To Raise Up To $5M Via Private Placement
Vuk Zdinjak
Wednesday, November 30, 2022
Psychedelic Stock Gainers And Losers From November 30, 2022
Benzinga Insights
Tuesday, November 29, 2022
Revive Therapeutics, Seelos Therapeutics Among Top Psychedelic Movers Of Today
Benzinga Insights
Monday, November 28, 2022
Revive Therapeutics, Compass Pathways Among Top Psychedelic Movers Of Today
Benzinga Insights
Friday, November 25, 2022
Psychedelic Stock Gainers And Losers From November 25, 2022
Benzinga Insights
Thursday, November 24, 2022
Psychedelic Stock Gainers And Losers From November 24, 2022
Benzinga Insights
Wednesday, November 23, 2022
Psychedelic Stock Gainers And Losers From November 23, 2022
Benzinga Insights
Tuesday, November 22, 2022
Psychedelic Stock Gainers And Losers From November 22, 2022
Benzinga Insights
Monday, November 21, 2022
Psychedelic Stock Gainers And Losers From November 21, 2022
Benzinga Insights
Friday, November 18, 2022
Biomind Labs, ATAI Life Sciences Among Top Psychedelic Movers Of Today
Benzinga Insights
Thursday, November 17, 2022
Revive Therapeutics, GH Research Among Top Psychedelic Movers Of Today
Benzinga Insights
Wednesday, November 16, 2022
Psychedelic Stock Gainers And Losers From November 16, 2022
Benzinga Insights
Tuesday, November 15, 2022
GH Research, Seelos Therapeutics Among Top Psychedelic Movers Of Today
Benzinga Insights
Thursday, November 10, 2022
Compass Pathways, Mind Medicine Among Top Psychedelic Movers Of Today
Benzinga Insights
Wednesday, November 09, 2022
Seelos Therapeutics, GH Research Among Top Psychedelic Movers Of Today
Benzinga Insights
Tuesday, November 08, 2022
Psychedelic Stock Gainers And Losers From November 8, 2022
Benzinga Insights
Monday, November 07, 2022
Compass Pathways, Allied Among Top Psychedelic Movers Of Today
Benzinga Insights
Thursday, November 03, 2022
Psychedelic Stock Gainers And Losers From November 3, 2022
Benzinga Insights
Wednesday, November 02, 2022
Compass Pathways, Small Pharma Among Top Psychedelic Movers Of Today
Benzinga Insights
Thursday, October 27, 2022
Revive Therapeutics, Small Pharma Among Top Psychedelic Movers Of Today
Benzinga Insights
Wednesday, October 26, 2022
Psychedelic Stock Gainers And Losers From October 26, 2022
Benzinga Insights
Tuesday, October 25, 2022
Psychedelic Stock Gainers And Losers From October 25, 2022
Benzinga Insights
Friday, October 21, 2022
Allied, Small Pharma Among Top Psychedelic Movers Of Today
Benzinga Insights
Tuesday, October 18, 2022
Psychedelic Stock Gainers And Losers From October 18, 2022
Benzinga Insights
Monday, October 17, 2022
Psychedelic Stock Gainers And Losers From October 17, 2022
Benzinga Insights
Friday, October 14, 2022
Small Pharma, Cybin Among Top Psychedelic Movers Of Today
Benzinga Insights
Wednesday, October 12, 2022
Psychedelic Stock Gainers And Losers From October 12, 2022
Benzinga Insights
Tuesday, October 11, 2022
Numinus Wellness, Small Pharma Among Top Psychedelic Movers Of Today
Benzinga Insights
Monday, October 10, 2022
Psychedelic Stock Gainers And Losers From October 10, 2022
Benzinga Insights
Thursday, October 06, 2022
Psychedelic Stock Gainers And Losers From October 6, 2022
Benzinga Insights
Tuesday, October 04, 2022
Allied, GH Research Among Top Psychedelic Movers Of Today
Benzinga Insights
Monday, October 03, 2022
Cybin, GH Research Among Top Psychedelic Movers Of Today
Benzinga Insights
Friday, September 30, 2022
Allied, Revive Therapeutics Among Top Psychedelic Movers Of Today
Benzinga Insights
Thursday, September 29, 2022
Allied, Compass Pathways Among Top Psychedelic Movers Of Today
Benzinga Insights
Wednesday, September 28, 2022
Psychedelic Stock Gainers And Losers From September 28, 2022
Benzinga Insights
Tuesday, September 27, 2022
Biomind Labs, Allied Among Top Psychedelic Movers Of Today
Benzinga Insights
Monday, September 26, 2022
Small Pharma, Revive Therapeutics Among Top Psychedelic Movers Of Today
Benzinga Insights
Friday, September 23, 2022
Will Cannabis Entrepreneurs Switch To Psychedelics?
Andrew Ward
Thursday, September 22, 2022
Psychedelic Stock Gainers And Losers From September 22, 2022
Benzinga Insights
Show More
